Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature

Daniel J Adams1,2, Josephine B Barone1, Cade M Nylund2

  • 1Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.

Insights

Community-associated Clostridioides difficile infection (CA-CDI) is rising in children, often acquired outside hospitals. Risk factors include antibiotic use and underlying health conditions, with most cases being mild but some severe or recurrent.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Clostridioides difficile infection (CDI) in children is increasingly recognized as a community-acquired issue.
  • The rising incidence of community-associated CDI (CA-CDI) in pediatric populations is noted, though diagnostic challenges and the role of C. difficile in very young children warrant further investigation.
  • Established risk factors for CA-CDI in children include antibiotic exposure, acid suppression therapy, healthcare contact, and proximity to infected individuals.

Purpose of the Study:

  • To review the epidemiology and clinical features of community-associated Clostridioides difficile infection in children.
  • To identify risk factors and common clinical presentations of CA-CDI in pediatric patients.
  • To highlight the need for improved understanding and prevention strategies for community-based C. difficile transmission in children.

Main Methods:

  • Literature review of studies focusing on pediatric CA-CDI.
  • Analysis of risk factors, including medication use and comorbidities.
  • Examination of clinical outcomes, severity, and recurrence rates in children with CA-CDI.

Main Results:

  • CA-CDI is more prevalent in the community than healthcare settings for children.
  • Children with chronic gastrointestinal or immune-compromising conditions are at higher risk.
  • While most CA-CDI cases are mild and managed outpatient, a subset can be severe, requiring hospitalization, and approximately 10% experience recurrence.

Conclusions:

  • Community-acquired Clostridioides difficile infection is a significant concern in pediatric populations.
  • Effective prevention strategies targeting community spread are necessary, as current infection control guidance primarily addresses hospital settings.
  • Further research is needed to elucidate the precise role of C. difficile in young children and optimize diagnostic and management approaches for CA-CDI.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.8K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
23